Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 5Uterine Cervical Dysplasia 4Prostatic Neoplasms 4Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Thyroid Nodule 1Retinoblastoma 1Prostate Adenocarcinoma 1Precancerous Conditions 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Oropharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Female Urogenital Diseases and Pregnancy Complications 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Radiosurgery 2Watchful Waiting 1Proton Therapy 1Observation 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostate Adenocarcinoma × Watchful Waiting × Clear all
NCT00887432 2021-10-26

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

Roswell Park Cancer Institute

Phase NA Completed
132 enrolled 11 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡